However, genomic studies have revealed the presence of mutations in genes associated with epigenetic modification (ASXL1, DNMT3A, IDH1/2, TET2, EZH2 and MLL) in a significant proportion of AML patients [26]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.